These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 3260653

  • 21. 1-Methyl-4-phenyl-pyridinium-induced inhibition of nicotinamide adenosine dinucleotide cytochrome c reductase.
    Poirier J, Barbeau A.
    Neurosci Lett; 1985 Nov 20; 62(1):7-11. PubMed ID: 3877888
    [Abstract] [Full Text] [Related]

  • 22. Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse.
    Perry TL, Yong VW, Jones K, Wall RA, Clavier RM, Foulks JG, Wright JM.
    Neurosci Lett; 1985 Aug 05; 58(3):321-6. PubMed ID: 3876525
    [Abstract] [Full Text] [Related]

  • 23. Effect of methyl methacrylate on mitochondrial function and structure.
    Bereznowski Z.
    Int J Biochem; 1994 Sep 05; 26(9):1119-27. PubMed ID: 7988736
    [Abstract] [Full Text] [Related]

  • 24. Energy-driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP.
    Ramsay RR, Dadgar J, Trevor A, Singer TP.
    Life Sci; 1986 Aug 18; 39(7):581-8. PubMed ID: 3488484
    [Abstract] [Full Text] [Related]

  • 25. The mechanism of action of MPTP and MPP+ on endogenous dopamine release from the rat corpus striatum superfused in vitro.
    Chang GD, Ramirez VD.
    Brain Res; 1986 Mar 12; 368(1):134-40. PubMed ID: 3485463
    [Abstract] [Full Text] [Related]

  • 26. Participation of brain monoamine oxidase B form in the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: relationship between the enzyme inhibition and the neurotoxicity.
    Kinemuchi H, Arai Y, Toyoshima Y.
    Neurosci Lett; 1985 Jul 31; 58(2):195-200. PubMed ID: 3876524
    [Abstract] [Full Text] [Related]

  • 27. The effects of pyridinium salts, structurally related compounds of 1-methyl-4-phenylpyridinium ion (MPP+), on tyrosine hydroxylation in rat striatal tissue slices.
    Hirata Y, Sugimura H, Takei H, Nagatsu T.
    Brain Res; 1986 Nov 12; 397(2):341-4. PubMed ID: 3099974
    [Abstract] [Full Text] [Related]

  • 28. Depletion of norepinephrine in mouse heart by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mimicked by 1-methyl-4-phenylpyridinium (MPP+) and not blocked by deprenyl.
    Fuller RW, Hemrick-Luecke SK.
    Life Sci; 1986 Nov 03; 39(18):1645-50. PubMed ID: 3095601
    [Abstract] [Full Text] [Related]

  • 29. Effect of styrene and other alkyl benzene derivatives on oxidation of FAD- and NAD-linked substrates in rat liver mitochondria.
    Mickiewicz W, Rzeczycki W.
    Biochem Pharmacol; 1988 Dec 01; 37(23):4439-44. PubMed ID: 2904817
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of type A monoamine oxidase by 1-methyl-4-phenylpyridine.
    Takamidoh H, Naoi M, Nagatsu T.
    Neurosci Lett; 1987 Jan 27; 73(3):293-7. PubMed ID: 3494215
    [Abstract] [Full Text] [Related]

  • 31. The neurotoxins 1-methyl-4-phenylpyridinium and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine are substrates for the organic cation transporter in renal brush border membrane vesicles.
    Sokol PP, Holohan PD, Ross CR.
    J Pharmacol Exp Ther; 1987 Jul 27; 242(1):152-7. PubMed ID: 2956410
    [Abstract] [Full Text] [Related]

  • 32. A redox reaction between MPP+ and MPDP+ to produce superoxide radicals does not impair mitochondrial function.
    Walker MJ, Jenner P, Marsden CD.
    Biochem Pharmacol; 1991 Jul 25; 42(4):913-9. PubMed ID: 1651082
    [Abstract] [Full Text] [Related]

  • 33. Changes in lipid peroxidation induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium in mouse brain homogenates.
    Ríos C, Tapia R.
    Neurosci Lett; 1987 Jun 26; 77(3):321-6. PubMed ID: 3497366
    [Abstract] [Full Text] [Related]

  • 34. MPP+-induced increases in extracellular potassium ion activity in rat striatal slices suggest that consequences of MPP+ neurotoxicity are spread beyond dopaminergic terminals.
    Hollinden GE, Sanchez-Ramos JR, Sick TJ, Rosenthal M.
    Brain Res; 1988 Dec 20; 475(2):283-90. PubMed ID: 3265070
    [Abstract] [Full Text] [Related]

  • 35. The mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity: role of intracellular calcium.
    Kass GE, Wright JM, Nicotera P, Orrenius S.
    Arch Biochem Biophys; 1988 Feb 01; 260(2):789-97. PubMed ID: 2963592
    [Abstract] [Full Text] [Related]

  • 36. Peripheral effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its main metabolite 1-methyl-4-phenylpyridinium ion (MPP+) in the rat.
    Algeri S, Ambrosio S, Garofalo P, Gerli P.
    Eur J Pharmacol; 1987 Sep 11; 141(2):309-12. PubMed ID: 3500067
    [Abstract] [Full Text] [Related]

  • 37. MPTP and MPTP analogs induced cell death in cultured rat hepatocytes involving the formation of pyridinium metabolites.
    Singh Y, Swanson E, Sokoloski E, Kutty RK, Krishna G.
    Toxicol Appl Pharmacol; 1988 Nov 11; 96(2):347-59. PubMed ID: 3143167
    [Abstract] [Full Text] [Related]

  • 38. Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria.
    Ramsay RR, Singer TP.
    J Biol Chem; 1986 Jun 15; 261(17):7585-7. PubMed ID: 3486869
    [Abstract] [Full Text] [Related]

  • 39. The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.
    Bradbury AJ, Costall B, Domeney AM, Testa B, Jenner PG, Marsden CD, Naylor RJ.
    Neurosci Lett; 1985 Oct 24; 61(1-2):121-6. PubMed ID: 2417166
    [Abstract] [Full Text] [Related]

  • 40. Model study on the bioreduction of paraquat, MPP+, and analogs. Evidence against a "redox cycling" mechanism in MPTP neurotoxicity.
    Frank DM, Arora PK, Blumer JL, Sayre LM.
    Biochem Biophys Res Commun; 1987 Sep 30; 147(3):1095-104. PubMed ID: 3499150
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.